SCHEMBL4285506

SCHEMBL4285506

Fc1ccc(-c2nc(S)[nH]c2-c2ccncc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.69
MAPK13 O15264 13/20 0.69
MAPK12 P53778 13/20 0.69
MAPK11 Q15759 13/20 0.69
GCGR P47871 11/20 0.69
CSNK1D P48730 5/20 0.69
MAPK9 P45984 4/20 0.69
PRKD3 O94806 3/20 0.69
MAP4K4 O95819 3/20 0.69
FRK P42685 3/20 0.69
CSNK1A1 P48729 3/20 0.69
GSK3B P49841 3/20 0.69
CLK4 Q9HAZ1 3/20 0.69
PTK6 Q13882 2/20 0.69
PRKD2 Q9BZL6 2/20 0.69
ALOX5 P09917 5/20 0.62
BRAF P15056 2/20 0.62
CSNK1E P49674 3/20 0.61
RAF1 P04049 2/20 0.61
PRKACA P17612 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5098384 1.00 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL5435606 0.92 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9435546 0.90 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL15075603 0.82 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL19868925 0.82 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL11267958 0.82 MAPK14 (0.50) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL27335373 0.81 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL6168758 0.81 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9340175 0.80 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9339561 0.80 MAPK14 (0.64) MAPK14MAPK13MAPK12MAPK11GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090098536-A1 Method for subgroup analysis in subjects having or being suspected of having inflammatory disease, use of anti-p38MAPK antibodies, kits and their use C-A-I-R- BIOSCIENCES GMBH (DE) 2009-04-16 US disclosed
US-7442713-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE GMBH (DE) 2008-10-28 US disclosed
EP-1909102-A1 Method for subgroup analysis in subjects having or being suspected of having inflammatory disease, use of anti-p38mapk antibodies, kits and their use c-a-i-r biosciences GmbH (DE) 2008-04-09 EP disclosed
EP-0994858-A1 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES Ortho-McNeil Pharmaceutical, Inc. (US) 2000-04-26 EP disclosed
US-6040320-A ANTIINFLAMMATORY AGENT FOR TREATING DISEASES ASSOCIATED WITH OVERPRODUCTION OF INFLAMMATORY CYTOKINES, SUCH AS RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISEASE, SEPTIC SHOCK, OSTEOPOROSIS, AND OSTEOARTHRITIS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-03-21 US disclosed
WO-1999003837-A1 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-01-28 WO disclosed
EP-0321490-B1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BEECHAM CORP (US) 1994-06-22 EP disclosed
EP-0321490-A4 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. SMITHKLINE BECKMAN CORP (US) 1990-05-14 EP disclosed
EP-0321490-A1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. SMITHKLINE BECKMAN CORP (US) 1989-06-28 EP disclosed
WO-1988001167-A1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BECKMAN CORPORATION (US) 1988-02-25 WO disclosed
WO-1988001169-A1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BECKMAN CORPORATION (US) 1988-02-25 WO disclosed
US-4175127-A ANTIARTHRITIC AGENTS SMITHKLINE CORPORATION (US) 1979-11-20 US disclosed